All News
28781 AI-summarized articles, newest first - page 719 of 1200

Rivian (RIVN) Focuses on R2 Launch Amid Rising Oil Prices
Rivian (RIVN) aims to improve its market position as oil prices rise, which has increased consumer interest in electric vehicles. The company is launching a lower-cost R2 model intended to appeal to mass-market buyers. While Rivian claims to have successfully produced award-winning vehicles, it has not yet generated positive earnings. The success of the R2 model could influence Rivian's path to becoming sustainably profitable, but execution remains a critical factor for the company.
Read More: Rivian (RIVN) Focuses on R2 Launch Amid Rising Oil Prices
On The Border Closes 60 Locations After Chapter 11 Bankruptcy
On The Border Mexican Grill & Cantina has closed all of its company-owned restaurants across the U.S., totaling 60 locations as of June 12, 2026. The chain had previously filed for Chapter 11 bankruptcy in March 2025. After being acquired by Pappas Restaurants in May 2025, some locations had reopened but ultimately led to this decision. The closures affect cities such as Oklahoma City, Grand Rapids, and Wichita Falls, while franchise locations will remain operational.
Read More: On The Border Closes 60 Locations After Chapter 11 Bankruptcy
MannKind Corporation (MNKD) Price Target Raised to $11 by Wells Fargo
On June 1, Wells Fargo increased its price target for MannKind Corporation (MNKD) from $10 to $11, maintaining an Overweight rating. This adjustment is attributed to the recent FDA approval of Afrezza Inhalation Powder for pediatric patients aged 6 and older. MannKind also indicated the possibility of receiving up to $35 million in development milestones along with a 10% royalty on net sales. These developments enhance MNKD's potential in the biopharmaceutical market, particularly in treating diabetes in children and adolescents.
Read More: MannKind Corporation (MNKD) Price Target Raised to $11 by Wells Fargo
Kosmos Energy (KOS) Q1 2026 Earnings Performance Surpasses Market
Kosmos Energy Ltd. (KOS) reported a year-to-date return exceeding the market by 221%. On May 27, Mizuho raised the price target to $3 from $2 while downgrading the stock from Neutral to Underperform. The company’s net debt-to-EBITDA is projected to be 1.8 times by year-end, compared to a peer average of nearly 0.5 times. Kosmos maintains its gross cargo guidance at 32-36 LNG cargos for the upcoming year, anticipating a rebound in volumes later due to cooler temperatures.
Read More: Kosmos Energy (KOS) Q1 2026 Earnings Performance Surpasses Market
UWM Holdings (UWMC) Hits All-Time Low Amid Market Concerns
UWM Holdings Corporation (UWMC) shares reached an all-time low the day prior, according to a report by Keefe Bruyette. This decline has been attributed to concerns regarding the company's leverage in a persistently high mortgage rate environment. Keefe Bruyette maintains a Market Perform rating with a price target of $4.50. Additionally, UWM's broker channel share is projected to grow from 28% to over 50%, highlighting potential for future growth despite current weaknesses.
Read More: UWM Holdings (UWMC) Hits All-Time Low Amid Market Concerns
USAS Price Target Increased to C$12 by BMO Capital on Performance
BMO Capital has raised the price target for Americas Gold and Silver Corporation (USAS) from C$10 to C$12, maintaining an Outperform rating. The company reported strong operational performance with a year-over-year quarterly revenue growth of 187.90% and highlighted its sustained production momentum at the Galena Complex. Over the past three years, USAS has outperformed the market by 285%. This positive outlook and operational focus on antimony could create further investor interest in the stock.
Read More: USAS Price Target Increased to C$12 by BMO Capital on Performance
i-80 Gold Corp. (IAUX) Price Target Raised to $2.60 from $2
On June 2, Freedom Broker raised the price target for i-80 Gold Corp. (IAUX) to $2.60 from $2, maintaining a Buy rating. This decision stems from i-80’s operational improvements in Q1, which included increased gold sales volumes and higher realized gold prices. The company successfully secured $787.5 million in funding to support its development plans, including the Granite Creek and Cove projects. i-80’s one-year return stands at 120.97%, surpassing the overall market return of 29.23%, indicating strong investment potential.
Read More: i-80 Gold Corp. (IAUX) Price Target Raised to $2.60 from $2
Iovance Biotherapeutics (IOVA) Receives Conditional Approval for Amtagvi
Iovance Biotherapeutics, Inc. (IOVA) received conditional approval for Amtagvi from the Therapeutic Goods Administration of Australia on June 4, 2026. Following this, the stock surged from low levels reported on June 3, although it has since returned to pre-approval prices. The management forecasts Q2 revenue from Amtagvi to be between $79 million and $81 million. Despite a price target adjustment from $16 to $14 by Chardan, 80% of analysts remain bullish on IOVA, indicating ongoing investor interest.
Read More: Iovance Biotherapeutics (IOVA) Receives Conditional Approval for Amtagvi
AtaiBeckley Inc. (ATAI) Target Price $25 with 561.38% Upside Potential
AtaiBeckley Inc. (ATAI) maintains a Buy rating from H.C. Wainwright with a price target of $25, indicating a potential upside of 561.38%. This valuation follows a management discussion on June 2 about BPL-003, a treatment for depression currently in Phase 3 trials. Furthermore, the company has launched a Patient Impact Grant Program, providing three $20,000 grants aimed at enhancing mental health outcomes. As a clinical-stage biopharmaceutical company founded in 2018, ATAI is focused on developing mental health treatments in North America and Europe.
Read More: AtaiBeckley Inc. (ATAI) Target Price $25 with 561.38% Upside Potential
Dow Jones Futures Test Amid SpaceX Developments
Dow Jones futures have indicated a trial period as investors assess market reactions to current developments, particularly with SpaceX. Notable stocks including those in the aerospace sector are being watched closely, with several identified in buy areas. While exact trading volumes were not provided, these shifts could influence broader market sentiment. Movements in major indices will be relevant for investors to consider amidst these developments.
Read More: Dow Jones Futures Test Amid SpaceX Developments
Rocket Lab (RKLB) Valuation Hits $59 Billion Amid Space IPO Surge
Rocket Lab (RKLB) has realized a market valuation of approximately $59 billion as of June 13 following significant interest in space stocks triggered by Elon Musk's SpaceX debut on June 12. The IPO was the largest ever, with SpaceX shares closing at around $161, resulting in a market capitalization of $2.1 trillion. Jacob Keeton, a prominent investor in Rocket Lab, has reported $3 million in gains from his investment of 11,000 shares. The global space economy is projected to grow from $626 billion in 2025 to $1.01 trillion by 2034 according to Novaspace's Space Economy Report.
Read More: Rocket Lab (RKLB) Valuation Hits $59 Billion Amid Space IPO Surge
Adobe (ADBE) Price Target Cut to $350 Ahead of Earnings Release
Stifel has lowered its price target for Adobe Inc. (ADBE) from $400 to $350, while maintaining a Buy rating. Analyst J. Parker Lane anticipates an organic revenue beat of approximately 1.5% for the upcoming quarter, despite concerns regarding Adobe’s near-term outlook. Citigroup also raised its price target from $253 to $264, suggesting a potential upside of about 14%. Both firms acknowledge challenges related to the fiscal 2026 outlook and pricing benefits in the second half of the year.
Read More: Adobe (ADBE) Price Target Cut to $350 Ahead of Earnings Release
CoreWeave (CRWV) Launches AI Capabilities Reducing Costs by 40%
CoreWeave Inc. (CRWV) announced on May 28 the launch of its unified agentic AI capabilities, which create a feedback loop between model training and inference. This system allows enterprises to post-train large language models with a promise to reduce costs by up to 40% and accelerate training by approximately 1.4 times. The integration includes components like serverless reinforcement learning and production inference. Chen Goldberg, Executive Vice President, emphasized the ability for agents to continuously improve from real-world experience, highlighting CRWV's potential to enhance AI reliability and expedite advancements towards superintelligence.
Read More: CoreWeave (CRWV) Launches AI Capabilities Reducing Costs by 40%
Boston Scientific (BSX) Price Target Cut to $64 by Truist
Truist has decreased its price target for Boston Scientific Corp. (BSX) from $85 to $64 while maintaining a Buy rating. This revision comes after management indicated slowing growth in the U.S. market for the Watchman device. Goldman Sachs also cut its target price for BSX from $81 to $71, while still offering a Buy rating, noting expected revenue growth of at least 7% and a double-digit increase in EPS. The adjustments reflect analysts' concerns over the product's performance but confidence in BSX's broader financial profile.
Read More: Boston Scientific (BSX) Price Target Cut to $64 by Truist
Intuit (INTU) Target Price Reduced from $600 to $500 by Analyst
Intuit Inc. (INTU) saw its price target lowered from $600 to $500 by Mizuho analyst Siti Panigrahi on May 26, while maintaining an Outperform rating. This adjustment follows a perceived weakness in the company's TurboTax platform, which contributed to a decline post-earnings. Despite this, Panigrahi remains optimistic about Intuit's long-term growth potential, particularly through TurboTax Live and the assisted tax market. Intuit continues to enhance its offerings, integrating AI with platforms such as Mailchimp to support small and mid-sized enterprises.
Read More: Intuit (INTU) Target Price Reduced from $600 to $500 by Analyst
Chewy (CHWY) Price Target Downgraded to $40 by Mizuho
Mizuho maintains an Outperform rating for Chewy Inc. (CHWY), but lowered its price target from $50 to $40 on June 3, citing high consensus expectations. The firm anticipates a shift to the lower half of the preliminary FY26 guidance range due to declining demand patterns. Barclays also lowered its price target to $40 while noting a 50% decline in stock price over the past two years. Despite long-term growth opportunities in various sectors, short-term catalysts remain unclear for Chewy's stock.
Read More: Chewy (CHWY) Price Target Downgraded to $40 by Mizuho
Guidewire Software (GWRE) Reports Q3 Revenue of $372.5 Million
Guidewire Software Inc. (GWRE) reported third-quarter revenue of $372.5 million, surpassing the consensus expectation of $356.09 million on June 5. Citizens adjusted its target price for GWRE from $300 to $220, indicating an adjusted upside potential of almost 89%. CEO Mike Rosenbaum emphasized the company's momentum and confidence in achieving a record-breaking fourth quarter as insurers increasingly shift operations to its cloud-based solutions. Despite the mixed results, Citizens reiterated an Outperform rating on the stock, reflecting optimism about upcoming performance supported by successful deal executions.
Read More: Guidewire Software (GWRE) Reports Q3 Revenue of $372.5 Million
Iran Deal Implications for Federal Reserve and Markets
The article discusses the potential impact of an Iran deal on Federal Reserve policy. While no concrete data or specific numbers are provided, it suggests that such a deal may not influence the Fed's stance on interest rates. This ambiguity could create uncertainty in financial markets. Thus, traders and investors should continue to monitor developments regarding the Iran negotiations and their consequences on economic policy.
Read More: Iran Deal Implications for Federal Reserve and Markets
Gold Prices Rise as Vintage Luxury Watches Melt Amid Demand
The rising demand for gold has led to some vintage luxury watches being melted down for their precious metal content. The fluctuation in gold prices can impact the luxury goods market, influencing consumer behavior and investment decisions. In recent months, the price of gold has seen notable increases, which may further affect the valuation of such luxury items. This trend could indicate a shift in how collectors and investors perceive the value of watches in the context of rising gold values.
Read More: Gold Prices Rise as Vintage Luxury Watches Melt Amid Demand
Intellia (NTLA) Reports Phase 3 Results for HAE Gene Therapy
Intellia (NTLA) has presented Phase 3 results for its gene therapy, lonvo-z, aimed at treating hereditary angioedema (HAE). The data indicates significant improvements for patients, although specific numerical outcomes were not disclosed in the summary. The advancement in this clinical trial could enhance Intellia's market position and viability in the gene therapy space, impacting investor confidence. The results will likely influence future investments and strategies within the biotech sector.
Read More: Intellia (NTLA) Reports Phase 3 Results for HAE Gene Therapy
China's Retaliation Possible: Pentagon Targets Top Tech Firms
China's commerce ministry expressed strong dissatisfaction with the Pentagon's recent update to its restricted list, which includes major firms like Alibaba (BABA), Baidu (BIDU), BYD (BYDDF), and NIO (NIO). This list, part of U.S. national security measures, prevents the Defense Department from contracting with these companies starting in 2027. The update reflects escalating geopolitical tensions between the U.S. and China, raising concerns about potential retaliation from Beijing. Chinese officials emphasized the need for fair treatment of firms, indicating a precarious balance in U.S.-China relations.
Read More: China's Retaliation Possible: Pentagon Targets Top Tech Firms
US-Iran Peace Deal Signing Expected Within 24 Hours
Pakistan's Prime Minister has announced that a peace deal between the US and Iran is anticipated to be signed within 24 hours. This potential agreement could influence geopolitical stability in the region and affect oil prices, although no specific data or figures were provided. The announcement highlights ongoing diplomatic efforts which may impact foreign relations and market sentiment. Traders and investors are closely monitoring this situation for any shifts in market dynamics related to related industries.
Read More: US-Iran Peace Deal Signing Expected Within 24 Hours
U.S. Soccer World Cup Opener: 4-1 Victory Over Paraguay
In their first home World Cup match in 32 years, the U.S. soccer team achieved a 4-1 victory over Paraguay. Folarin Balogun scored two goals in the first half, contributing to a halftime lead of 3-0, which is the largest for the team in World Cup history. Notably, Gio Reyna added a fourth goal in injury time, marking the first time the U.S. scored four goals in a World Cup match since the tournament's inception in 1930. This performance signifies a potential shift in the team's competitive dynamism under coach Mauricio Pochettino, potentially drawing greater fan engagement.
Read More: U.S. Soccer World Cup Opener: 4-1 Victory Over Paraguay
Iran and U.S. Peace Deal Expected in 24 Hours, Says Pakistan PM
The Prime Minister of Pakistan has announced that Iran and the U.S. are set to sign a peace deal within 24 hours. This development could impact geopolitical dynamics in the region and potentially influence oil market performance. The official confirmation of the agreement remains pending, which makes its market implications uncertain. Key figures related to economic sanctions or trade routes may be detailed post-signing to assess overall impact.
Read More: Iran and U.S. Peace Deal Expected in 24 Hours, Says Pakistan PM